Viable Malignant Cells After Primary Chemotherapy for Disseminated Nonseminomatous Germ Cell Tumors: Prognostic Factors and Role of Postsurgery Chemotherapy—Results From an International Study Group
Top Cited Papers
- 15 May 2001
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (10) , 2647-2657
- https://doi.org/10.1200/jco.2001.19.10.2647
Abstract
PURPOSE: To assess the value of postsurgery chemotherapy in patients with disseminated nonseminomatous germ-cell tumors (NSGCTs) and viable residual disease after first-line cisplatin-based chemoth...Keywords
This publication has 41 references indexed in Scilit:
- The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patientsEuropean Journal Of Cancer, 2000
- Subgroup analysis and other (mis)uses of baseline data in clinical trialsThe Lancet, 2000
- Testicular Germ-Cell CancerNew England Journal of Medicine, 1997
- Chemotherapy in adult germ cell tumorsCritical Reviews in Oncology/Hematology, 1996
- Para‐aortic Lymphadenectomy after Chemotherapy for Metastatic Non‐seminomatous Germ Cell Tumours: Prognostic Value and Therapeutic BenefitBritish Journal of Urology, 1993
- Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgeryEuropean Journal of Cancer and Clinical Oncology, 1991
- The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumorsCancer, 1990
- The Importance of Prognostic Factors in the Individual Treatment of Patients with Disseminated Germ Cell TumoursBritish Journal of Urology, 1990
- Excision of residual masses after platinum based chemotherapy for non-seminomatous germ cell tumoursEuropean Journal of Cancer and Clinical Oncology, 1989
- Immediate Adjuvant Chemotherapy versus Observation with Treatment at Relapse in Pathological Stage II Testicular CancerNew England Journal of Medicine, 1987